• Profile
Close

Skeletal muscle loss during neoadjuvant chemotherapy is an independent risk factor for postoperative infectious complications in patients with advanced esophageal cancer

Oncology Aug 30, 2018

Motoori M, et al. - In a total of 83 patients with esophageal cancer undergoing neoadjuvant chemotherapy (NACT) followed by esophagectomy, researchers assessed the impact of sarcopenia, changes in body composition, and adverse events during NACT on postoperative complications. They evaluated body composition before chemotherapy and before esophagectomy. Findings revealed that, loss of skeletal muscle mass during NACT was identified as a significant risk factor for postoperative infectious complications in patients with esophageal cancer. Postoperative infectious complications could be attenuated by preventing severe adverse events.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay